Early tumour response as a survival predictor in previously- treated patients receiving triplet hepatic artery infusion and intravenous cetuximab for unresectable liver metastases from wild-type KRAS colorectal cancer
Domains
Life Sciences [q-bio]
Fichier principal
WRAP_flaccept_ak_optiliv_ms_er_13june2016_rev1_fl.pdf (789.2 Ko)
Télécharger le fichier
Origin | Files produced by the author(s) |
---|